Q2 net sales reach $100M for Tarsus' XDEMVY
Tarsus aims to expand the lotilaner pipeline with potential treatments for ocular rosacea, Lyme disease and malaria.| Drug Discovery and Development
Tarsus aims to expand the lotilaner pipeline with potential treatments for ocular rosacea, Lyme disease and malaria.| Drug Discovery and Development
